Literature DB >> 21942990

Knowledge and attitudes of primary healthcare patients regarding population-based screening for colorectal cancer.

Maria Ramos1, Maria Llagostera, Magdalena Esteva, Elena Cabeza, Xavier Cantero, Manel Segarra, Maria Martín-Rabadán, Guillem Artigues, Maties Torrent, Joana Maria Taltavull, Joana Maria Vanrell, Mercè Marzo, Joan Llobera.   

Abstract

ABSTRACT:
BACKGROUND: The aim of this study was to assess the extent of knowledge of primary health care (PHC) patients about colorectal cancer (CRC), their attitudes toward population-based screening for this disease and gender differences in these respects.
METHODS: A questionnaire-based survey of PHC patients in the Balearic Islands and some districts of the metropolitan area of Barcelona was conducted. Individuals between 50 and 69 years of age with no history of CRC were interviewed at their PHC centers.
RESULTS: We analyzed the results of 625 questionnaires, 58% of which were completed by women. Most patients believed that cancer diagnosis before symptom onset improved the chance of survival. More women than men knew the main symptoms of CRC. A total of 88.8% of patients reported that they would perform the fecal occult blood test (FOBT) for CRC screening if so requested by PHC doctors or nurses. If the FOBT was positive and a colonoscopy was offered, 84.9% of participants indicated that they would undergo the procedure, and no significant difference by gender was apparent. Fear of having cancer was the main reason for performance of an FOBT, and also for not performing the FOBT, especially in women. Fear of pain was the main reason for not wishing to undergo colonoscopy. Factors associated with reluctance to perform the FOBT were: (i) the idea that that many forms of cancer can be prevented by exercise and, (ii) a reluctance to undergo colonoscopy if an FOBT was positive. Factors associated with reluctance to undergo colonoscopy were: (i) residence in Barcelona, (ii) ignorance of the fact that early diagnosis of CRC is associated with better prognosis, (iii) no previous history of colonoscopy, and (iv) no intention to perform the FOBT for CRC screening.
CONCLUSION: We identified gaps in knowledge about CRC and prevention thereof in PHC patients from the Balearic Islands and the Barcelona region of Spain. If fears about CRC screening, and CRC per se, are addressed, and if it is emphasized that CRC is preventable, participation in CRC screening programs may improve.

Entities:  

Year:  2011        PMID: 21942990      PMCID: PMC3190390          DOI: 10.1186/1471-2407-11-408

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


Background

Colorectal cancer (CRC) is a significant health problem in developed countries, both because of its high incidence and because it is accompanied by high mortality. An epidemiological analysis of all cancers in Spain indicated that CRC had the highest incidence and the second highest mortality rate for both genders. Every year, approximately 25,600 new cases of CRC are diagnosed [1] and, in 2008, 10,604 patients died from CRC (4,630 men and 5,974 women) (INEbase). An epidemiological study indicated that the incidence of CRC in Spain is increasing, but mortality therefore is declining [2]. CRC is one of the few types of cancer for which both primary and secondary prevention are possible. With respect to secondary prevention, the evidence strongly indicates that population-based screening using the fecal occult blood test (FOBT), and colonoscopy if FOBT results are positive, reduces both the incidence of and mortality from CRC [3]. Participation of a large proportion (more than 50%) of the population in testing is crucial for the success of screening programs [4]. Thus, it is necessary to ensure widespread compliance before implementation of a CRC screening program. The Theory of Reasoned Action indicates that intention to participate in a CRC screening program overlaps with the Theory of Planned Behavior, the most proximal determinant of participation [5,6]. Intention to participate is associated with a positive attitude toward screening, and knowledge of both CRC and cancer screening in general is an important prerequisite if a positive attitude toward CRC screening is to develop [7]. The knowledge of the general population about CRC is currently poor [7,8], and gender differences in attitudes toward CRC screening are apparent [9,10]. In Spain, a National Cancer Strategy promotes the development of population screening programs for CRC, and several regions are currently implementing such programs. No program has yet been implemented in the Balearic Islands (located in the western Mediterranean Sea) whereas, in Catalonia, after completion of a pilot study, a program will soon be extended to the entire region. The present work is part of a more comprehensive project that aims to assess the knowledge and attitudes of primary health care (PHC) professionals [11] and patients toward CRC screening. In particular, the present study is exploratory in nature, and precedes implementation of a population-based CRC screening program in the Balearic Islands. The present work was performed during implementation of a CRC screening program in Barcelona. We assessed the extent of knowledge of PHC patients about CRC, their attitudes toward population-based screening for this disease and gender differences in these respects. A secondary objective was to identify factors that might support the use of FOBT and colonoscopy in the context of CRC population-based screening

Methods

Design

This was a cross-sectional descriptive study based on a survey of adult patients visiting PHCs in the Balearic Islands (which had 1,014,405 inhabitants in 2007) and in the southern metropolitan area of Barcelona (with 1,275,679 inhabitants in 2007).

Study population

Patients 50 to 69 years of age who visited PHCs for any reason from January to June 2009 were included. Patients with a diagnosis of CRC or who had a terminal illness were excluded. In both areas, sample size was calculated assuming that 50% of PHC patients would participate in a population-based screening program. Using a confidence level of 95% and a precision of 5%, the estimated sample size was 384 patients for each area. Systematic sampling of participant nurse quotas was used. The first patient (and his/her companion) scheduled to be visited on Tuesdays and Thursdays in participant nurses' agendas were invited to participate in the study if they met inclusion criteria.

Data collection

We developed a questionnaire based on literature review [7,8,12-15]. In December 2008, we performed a pilot study by administering the questionnaire to 20 patients in one healthcare center. As a result, the wording and/or format of some questions were/was modified. Between January and June 2009, 30 nurses in the Balearic Islands and 29 nurses in Barcelona administered the final questionnaire during patient visits. All participants signed informed consent agreements. This study was approved by the Primary Health Care Research Committee, the Balearic Islands Ethics Committee for Clinical Research, and the Ethics Committee of the Primary Care Research Institut IDIAP Jordi Gol.

Variables

The questionnaire explored the following variables: sociodemographics; lifestyle (tobacco consumption, daily fruit and vegetable consumption, extent of physical exercise); history of chronic health problems, intestinal polyps, and cancer; use of PHC services; knowledge about cancer and CRC; past experience with cancer screening (mammography, cytology, FOBT, colonoscopy, prostate-specific antigen [PSA] measurement, and computed tomography [CT]); attitudes toward FOBT as a CRC screening tool and toward colonoscopy if an FOBT is positive; reasons for performing or not performing an FOBT; and rationales for undergoing or not undergoing colonoscopy. With respect to variables exploring knowledge and attitudes, the possible responses were: "I agree", "I disagree", or "I do not know". Questions on performance or non-performance of FOBT or colonoscopy were posed in multiple-choice format.

Statistical analysis

Answers to questionnaires were recorded in a in a Microsoft Access database using Teleform 4.0 for Windows. We determined the frequencies of all qualitative variables and assessed the normality of quantitative variables, the means and medians of which were calculated. All variables were explored by bivariate analysis for each gender. Next, we dichotomized the variables representing support or lack of support for FOBT and colonoscopy into two categories: "Feeling reluctant" (this category included: "No, I would not do it" and "I am not sure") and "Would support" (this category included: "Yes, I would do it"). Bivariate analysis was performed using these new variables without any change in the initial categories of the other variables. Next, two logistic regression analyses were performed; the first used support or lack of support for FOBT as the dependent variable, and the second support or lack of support for colonoscopy. In both equations, all independent variables had p-values of < 0.1 upon bivariate analysis. Backward logistic regression analysis was next performed. Independent variables were excluded from the model when no statistically significant relationships with the dependent variable were evident, and when the estimated coefficients did not change markedly from those yielded in the previous model employing the variable. Each new model was compared with the previous model by calculation of a likelihood ratio. SPSS version 13.0 for Windows was used for all statistical analysis.

Results

We collected 625 completed questionnaires from 24 PHC healthcare centers in the Balearic Islands and from 36 PHC centers in Barcelona. A total of 34 patients (5.2%), 67.6% of whom were male with a mean age of 58.6 years, refused to participate. Table 1 shows the demographic characteristics of participating patients. One in three (33%) participants reported visiting a healthcare center often or very often in the previous year, 43% from time-to-time, 21% occasionally, whereas 2% had not visited a center during the previous year. Most participants reported that they had high or very high confidence in PHC doctors and nurses (78% for each question).
Table 1

Patient characteristics

VariablesCategoriesCases (N = 625)Valid %Women % (N = 361)Men % (N = 261)
Age50-5412319.722.415.7
55-5914322.924.121.1
60-6417728.328.528.0
65-6918229.124.935.2

RegionBalearic islands25440.642.237.2
Barcelona37159.456.862.8

Educational level< Elementary school12119.722.715.9
Elementary school38562.763.262.0
High school7311.99.115.5
Bachelor's degree355.75.16.6

Job situationActive24239.035.543.2
Not active37861.064.556.8

SmokingYes9815.812.220.8
No51983.487.278.0

Eats fruit dailyYes58493.793.194.6
No396.36.95.4

Eats vegetables dailyYes54988.393.194.6
No7311.710.013.8

Practices physical activity DailyYes48678.376.381.2
No13421.623.718.5

Chronic health problemYes45277.777.178.6
No12321.121.720.2
Don't know71.21.21.2

Type of chronic health problemHypertension33052.852.154.4
Diabetes17528.022.435.6
Depression7912.617.56.1
Anxiety6610.613.96.1
Heart failure325.13.08.0
Renal failure142.21.43.4
Asthma274.34.24.2
COPD223.51.76.1
Irritable bowel162.63.01.1
Diverticulosis121.92.51.1
Ulcerative colitis40.60.60.8

History of polypsYes304.85.83.5
No56791.390.991.8
Don't know243.93.34.7

History of cancerYes6210.110.49.8
No54088.187.389.0
Don't know111.82.31.2

Type of cancerBreast20-5.5-
Skin132.11.43.1
Urinary bladder40.60.01.5
Lung20.30.30.4
Prostate8--3.1
Other111.81.42.3

Family history of colorectal cancerYes10817.521.112.5
No47277.174.480.8
Don't know335.44.56.7
Patient characteristics Table 2 shows respondent knowledge about cancer in general and CRC in particular. Most patients knew that many cancers could be avoided by giving up smoking and that diagnosis before symptom occurrence improved the chance of survival. However, only half of all respondents knew that more than 50% of CRC patients survive for 5 years after diagnosis or that exercise could help prevent CRC. It was also known that many cancers could be avoided by eating more fruit and vegetables and that intestinal polyps must be removed because they can become cancerous. Women had more knowledge of CRC symptoms than did men, and they were aware of the significance of bloody stools, diarrhea, and constipation, but not of other signs and symptoms, such as weight loss, tenesmus, and abdominal pain.
Table 2

Knowledge about cancer and colorectal cancer

QuestionsAnswersTotal % (N = 625)Women % (N = 361)Men % (N = 261)p
There are many types of cancerTrae94.395.093.50.729
False0.30.30.4
I don't know5.34.86.2

Some cancers can be curedTrae93.293.892.30.617
False3.42.84.2
I don't know3.43.43.5

Cancer is a fatal diseaseTrae27.927.029.10.801
False65.465.964.7
I don't know6.77.16.2

Many cancer cases could be avoided by doing more exerciseTrae45.139.453.10.003
False17.118.715.0
I don't know37.741.931.9

Many cancer cases could be avoided by giving up smokingTrae92.290.295.00.065
False2.83.12.3
I don't know5.06.72.7

Many cancer cases could be avoided by eating more fruits and vegetablesTrae69.968.871.30.266
False7.58.95.4
I don't know22.722.323.3

Cancer diagnosis before symptoms can improve chances of survivalTrae88.288.587.70.476
False1.00.61.5
I don't know10.810.910.7

More than half of colorectal cancer cases survive five years after diagnosisTrae44.745.343.80.759
False7.68.16.9
I don't know47.746.649.2

Intestinal polyps must be removed because they can become a cancerTrae64.266.860.60.224
False2.62.82.3
I don't know33.230.437.1

Which of the following symptoms indicate a colorectal cancerBloody stools72.276.566.30.006
Diarrhea-Constipation42.948.535.20.001
Abdominal pain23.624.123.00.775
Headache8.88.010.00.475
Fatigue37.939.635.60.317
Paleness32.034.328.70.163
Difficulty swallowing13.813.913.81.000
Weight loss55.661.547.50.001
Burning stomach15.614.716.90.502
Tenesmus22.224.918.40.063
Pain during defecation36.237.134.90.612
I don't know20.917.226.10.009
Knowledge about cancer and colorectal cancer A total of 82% of women and 38% of men had participated in screening tests for prevention of some type of cancer. Among women, 83.1% had undergone mammography, 68.1% cytology tests, 16.3% colonoscopies, 9.4% FOBTs, and 8.3% CT scans. Of all men, 36.4% had undergone PSA tests, 10.7% colonoscopies, 8.8% FOBTs, and 6.5% CT scans. Patients were asked how they would respond if a PHC doctor or nurse proposed that an FOBT be performed for CRC screening. A total of 88.8% of participants reported that they would undergo the test, 7.3% were not sure, and 3.9% indicated they would not. If the FOBT was positive and a colonoscopy was offered, 84.9% of participants reported that they would undergo the procedure, 5.9% were not sure, and 9.2% would not. Responses did not differ significantly between gender. Patients reported that their main reasons for performing the FOBT were that they cared about their health and that they believed in advice received from doctors and nurses (Figure 1). The main reasons why patients would not perform the FOBT were that they felt well and feared discovering cancer (Figure 2). Women reported cancer fears somewhat more frequently than did men, although the difference was not significant. Less than 20% of participants reported that they felt susceptible to CRC. The main reasons for undergoing colonoscopy were to seek reassurance that cancer was absent and the belief that, if a polyp or cancer was present, treatment was necessary (Figure 3). Fear of pain was the main reason for not undergoing colonoscopy, especially among women (Figure 4).
Figure 1

Reasons for performing a FOBT in % (Only participants that would do it or doubt = 599).

Figure 2

Reasons for not performing a FOBT in % (Only participants that wouldn't perform it or doubt = 69).

Figure 3

Reasons for undergoing a colonoscopy (Only participants that would undergo it or doubt = 558).

Figure 4

Reasons for not undergoing colonoscopy (Only participants that wouldn't undergo it or doubt = 92).

Reasons for performing a FOBT in % (Only participants that would do it or doubt = 599). Reasons for not performing a FOBT in % (Only participants that wouldn't perform it or doubt = 69). Reasons for undergoing a colonoscopy (Only participants that would undergo it or doubt = 558). Reasons for not undergoing colonoscopy (Only participants that wouldn't undergo it or doubt = 92). Bivariate analysis indicated that several factors were associated with reluctance to perform the FOBT (Table 3) and to undergo colonoscopy if the FOBT was positive (Table 4). In both instances, the knowledge that many forms of cancer can be prevented by performing more exercise and that cancer diagnosis before symptom onset can improve survival were associated with favorable views on the FOBT and colonoscopy. Knowledge of the main symptoms of colorectal cancer; experience with any screening test for cancer prevention; and a positive attitude toward colonoscopy (when FOBT was explored) or toward FOBT (when colonoscopy was explored) were the main factors associated with reluctance to undergo FOBT or colonoscopy.
Table 3

Bivariate analysis of factors associated (p < 0.1) with being reluctant to perform a FOBT for colorectal cancer early diagnosis

VariablesCategoriesReluctant (%)Would support (%)p
Job situationActive7.592.50.019
Not active13.686.4

Educational level< Elementary school16.883.20.082
Elementary school10.489.6
High school5.594.5
Bachelor's degree14.385.7

There are many types of cancerTrue10.389.70.044
False + don't know22.977.1

Cancer is a fatal diseaseTrue + don't know14.285.80.080
False9.590.5

Many cancer cases could be avoided by doing more exerciseTrue5.194.90.000
False + don't know15.984.1

Many cancer cases could be avoided by giving up smokingTrue10.090.00.013
False + don't know22.977.1

Many cancer cases could be avoided by eating more fruits and vegetablesTrue9.091.00.012
False + don't know16.283.8

Cancer diagnosis before symptoms can improve survivalTrue9.091.00.000
False + don't know26.873.2

Intestinal polyps must be removed, because they can become cancerTrue8.491.60.010
False + don't know15.384.7

Any screening test done for cancer preventionYes8.691.40.014
No15.584.5

PSA test done for cancer preventionYes5.294.80.051
No12.287.8

FOBT done for cancer preventionYes1.898.20.014
No12.187.9

Which of the following symptoms indicate a colorectal cancerBloody stoolsYes8.491.60.001
No18.281.8
Diarrhea-Constipation Yes7.492.60.010
No14.086.0
Abdominal painYes6.193.90.034
No12.787.3
FatigueYes7.692.40.035
No13.386.7
Weight lossYes8.991.10.055
No13.986.1
Burning stomachYes5.194.90.036
No12.287.8
TenesmusYes3.696.40.001
No13.386.7
Pain during defecationYes5.394.70.000
No14.585.5
I don't knowYes18.681.40.004
No9.190.9

In case FOBT were + and a colonoscopy were recommended, would you accept to undergo it?Yes5.294.80.000
No + I doubt44.655.4
Table 4

Bivariate analysis of factors associated (p < 0.1) with being reluctant to undergo a colonoscopy for colorectal cancer early diagnosis

VariablesCategoriesReluctant (%)Would support (%)p
RegionBalearic Islands10.090.00.004
Barcelona18.481.6

Job situationActive11.888.20.082
No active17.282.8

There are many types of cancerTrue14.285.80.028
False + don't know28.671.4

Many cancer cases could be avoided by doing more exerciseTrue10.489.60.008
False + don't know18.181.9

Many cancer cases could be avoided by eating more fruits and vegetablesTrue12.987.10.026
False + don't know20.179.9

Cancer diagnosis before symptoms can improve chances of survivalTrue12.487.60.000
False + don't know35.764.3

More than half of cases of colorectal cancer survive 5 years after diagnosisTrue10.789.30.009
False + don't know18.581.5

Intestinal polyps must be removed, because they can become cancerTrue12.187.90.017
False + don't know19.580.5

Any screening test done for cancer preventionYes12.787.30.067
No18.781.3

Colonoscopy done for cancer preventionYes3.496.60.001
No16.983.1

CT done for cancer preventionYes4.395.70.032
No15.984.1

Which of the following symptoms indicate a colorectal cancerBloody stoolsYes11.988.10.001
No23.476.6
Diarrhea-ConstipationYes10.989.10.012
No18.281.8
Abdominal painYes10.389.70.084
No16.583.5
FatigueYes9.490.60.002
No18.481.6
PalenessYes10.189.90.021
No17.382.7
Difficulty swallowingYes7.192.90.032
No16.283.8
Weight lossYes12.088.00.022
No18.881.2
Burning stomachYes7.292.80.019
No16.483.6
TenesmusYes6.593.50.001
No17.482.6
Pain during defecationYes8.092.00.000
No19.081.0
I don't knowYes24.475.60.002
No12.587.5

Would you accept to perform a FOBT for colorectal screening?Yes9.390.70.000
No + I doubt60.339.7
Bivariate analysis of factors associated (p < 0.1) with being reluctant to perform a FOBT for colorectal cancer early diagnosis Bivariate analysis of factors associated (p < 0.1) with being reluctant to undergo a colonoscopy for colorectal cancer early diagnosis Multivariate analysis indicated that patients who did not know that many cancers can be prevented by performing more exercise, and those who would not undergo colonoscopy if an FOBT was positive, were more reluctant to perform the FOBT for CRC screening (Table 5). With respect to colonoscopy, participants from Barcelona who did not know that early diagnosis of CRC was associated with improved prognosis, those who had never had colonoscopies, and those who would not perform the FOBT for CRC screening, were more reluctant to undergo colonoscopy.
Table 5

Multivariate analysis of factors associated with being reluctant to do a FOBT and a colonoscopy for colorectal cancer screening*

VariableCategoriesβpOR95% CI
Being reluctant to perform a FOBT

Labour situationActive1
No active0.6410.0721.9140.044-3.880
Many cancer cases could be avoided by doing more exerciseTrue1
False + don't know1.1550.0023.1741.542-6.532
FOBT done for cancer preventionYes1
No2.0320.0617.6310.912-63.822
Bloody stools is a symptom of colorectal cancerYes1
No0.6170.0661.8530.960-3.579
If FOBT were positive, would you accept to undergo a colonoscopy?Yes1
No + I doubt2.6030.00013.5077.144-25.536

Being reluctant to undergo a colonoscopy

RegionBalearic Islands1
Barcelona0.7980.0122.2201.188-4.149
Cancer diagnosis before symptoms can improve chances of survivalTrue1
False + don't know0.8220.0232.2761.117-4.635
More than half of cases of colorectal cancer survive 5 years after diagnosisTrue1
False + don't know0.5000.1011.6490.907-2.997
Colonoscopy done for cancer preventionYes1
No1.4780.0224.3831.238-15.514
Fatigue is a symptom of colorectal cancerYes1
No0.5050.1061.6570.898-3.058
Would you accept to perform a FOBT for colorectal screening?Yes1
No + I doubt2.7260.00015.2727.852-29.703

* Nagelkerke's R2: 0.352 for being reluctant to do a FOBT and 0.323 for being reluctant to do a colonoscopy

Multivariate analysis of factors associated with being reluctant to do a FOBT and a colonoscopy for colorectal cancer screening* * Nagelkerke's R2: 0.352 for being reluctant to do a FOBT and 0.323 for being reluctant to do a colonoscopy

Discussion

We examined the extent of knowledge about CRC in PHC patients from two regions of Spain, and the attitudes toward CRC and screening for the cancer. Our results indicate that knowledge about CRC in the general population could be improved, but that attitudes toward the FOBT and colonoscopy were generally positive. Our results also indicated some differences between men and women in attitudes toward CRC screening. This issue will be more thoroughly explored, in a qualitative manner, during the next phase of our study. Our patients showed clear gaps in knowledge about CRC prevention and symptoms, as also reported in previous studies [7,8,14]. Women had a better knowledge of CRC symptoms and men had more knowledge of CRC prevention. A previous study in the United Kingdom also found that women had more knowledge about CRC than did men [7]. Although a general knowledge of CRC is not enough to raise CRC awareness to the level required for participation in screening programs, such knowledge has been reported as essential for development of a positive attitude toward screening programs in some studies [7,16], but not in others [17]. Most of our PHC patients (88.8%) reported that they would support a population-based screening program for CRC that employed the FOBT followed by colonoscopy in instances of FOBT-positivity. The proportion of responsive PHC patients in the United Kingdom was similar [7], but fewer patients in Japan responded positively [16]. However, an intention to undergo CRC screening is not the same as actual participation in such screening. In particular, Herbert et al. showed that whereas over 80% of participants expressed an intention to participate in a CRC screening program, only 40% actually participated [12]. Thus, it is possible that our results were influenced by social desirability bias (over-reporting of expected behavior) and by the administration of the questionnaire in healthcare centers. One limitation of the present study is that our PHC patients may not be representative of the general population of Spain, the true target of population-based CRC screening. Spain has a free public healthcare system that covers 99% of the population. Thus, although our participants may not reflect the general population, they may be representative of those of lower socioeconomic status, and such subjects would benefit most from a campaign seeking to improve awareness of CRC screening [7]. In the present study, women reported more prior experience with cancer screening than did men. This reflects the existence of well-established screening programs for breast and cervical cancer. Thus, we expected to find differences between men and women regarding intention to participate in a CRC screening program [18], but we in fact found no gender-based difference in this variable, unlike what was noted in studies in the United Kingdom [19] and Catalonia [20], both of which reported higher participation by women in CRC screening programs. Fear of being diagnosed with cancer, and of pain during colonoscopy, were the principal reasons given, especially by women, for not wishing to participate in CRC screening. These observations agree with those of other studies [17,21] and with the views held by PHC professionals about their patients [11]. Also, patients perceived that the risk of developing CRC was low, as has also been observed in previous studies [8]. We found no between-gender difference in perceived fear of CRC, in contrast to the results of a previous qualitative study which found that women believed that CRC was more common in men, and the women thus felt less vulnerable to this cancer [22]. Factors associated with a positive attitude toward the FOBT and colonoscopy were diverse in nature and included knowledge about CRC primary prevention, of the symptoms of CRC, and of the benefits afforded by CRC screening. Moreover, positive attitudes toward the FOBT and colonoscopy were associated, and vice versa. Previous studies also found that the perceived benefits and barriers were the main factors associated with an intention to undergo colonoscopy after a positive FOBT [16]. In one previous work, compliance with the advice of the PHC doctor was associated with intention to perform the FOBT for colorectal cancer screening, and also with actual FOBT completion [12]. Another qualitative study found that lack of trust in doctors was a barrier to CRC screening [15]. In the present work, we found no association between a positive attitude toward CRC screening and patient confidence in the PHC doctor or nurse. We suggest further exploration of this issue, because previous experience has shown that PHC doctors play key roles in developing patient willingness to participate in CRC screening [23]. Our results showed that the knowledge that physical activity could protect against CRC was associated with a positive attitude toward the FOBT. Also, we observed that an understanding that early diagnosis of CRC is associated with better prognosis was associated with a positive attitude toward colonoscopy if an FOBT was positive. It is noteworthy that one-third of our subjects did not know that polyps should be removed because they can become cancerous. Together, our results indicate that developing knowledge on CRC preventability should be a key plank in the design of an awareness program promoting CRC population-based screening, as has been noted previously [17].

Conclusions

In summary, the present study has shown that PHC patients have knowledge gaps with respect to both the nature and prevention of CRC. Addressing patient cancer fears and emphasizing that CRC is preventable will be key elements in the successful promotion of CRC screening.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

MR, EC, ME, JMT, JMV, JL and GA designed the study; MR and ML led development of the projects in the Balearic Islands and Barcelona, respectively; MMR, XC, MS, and MT coordinated study work in their respective areas. MR and ME performed the statistical analysis, and MR drafted the manuscript. ME, EC, MM, MMR, XC, MS, GA, MT, JMT, JMV, JL and ML critically reviewed the draft and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/11/408/prepub
  18 in total

1.  Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002).

Authors:  S Winawer; J Faivre; J Selby; L Bertaro; T H-H Chen; O Kroborg; B Levin; J Mandel; C O'Morain; M Richards; G Rennert; A Russo; H Saito; B Semigfnovsky; B Wong; R Smith
Journal:  Ann Oncol       Date:  2005-01       Impact factor: 32.976

2.  Workgroup IV: public education. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002).

Authors:  R Hiatt; J Wardle; S Vernon; J Austoker; L Bistanti; S Fox; R Gnauck; D Iverson; M Mandelson; D Reading; R Smith
Journal:  Ann Oncol       Date:  2005-01       Impact factor: 32.976

3.  Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom.

Authors:  Kirsten McCaffery; Jane Wardle; Jo Waller
Journal:  Prev Med       Date:  2003-05       Impact factor: 4.018

4.  Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation.

Authors:  C Herbert; G Launoy; M Gignoux
Journal:  Eur J Cancer Prev       Date:  1997-02       Impact factor: 2.497

5.  Psychosocial factors associated with the adherence to a colorectal cancer screening program.

Authors:  Margalida Gili; Miquel Roca; Victoria Ferrer; Antoni Obrador; Elena Cabeza
Journal:  Cancer Detect Prev       Date:  2006-09-11

6.  Colorectal cancer knowledge is not associated with screening compliance or intention.

Authors:  David S Weinberg; Suzanne Miller; Michelle Rodoletz; Brian Egleston; Linda Fleisher; Joanne Buzaglo; Eileen Keenan; Jaime Marks; Eric Bieber
Journal:  J Cancer Educ       Date:  2009       Impact factor: 2.037

7.  Perspectives on colorectal cancer screening: a focus group study.

Authors:  Vivek Goel; Ross Gray; Pam Chart; Marg Fitch; Fred Saibil; Yola Zdanowicz
Journal:  Health Expect       Date:  2004-03       Impact factor: 3.377

8.  Knowledge, attitudes, and preventive practices about colorectal cancer among adults in an area of Southern Italy.

Authors:  Alessandra Sessa; Rossella Abbate; Gabriella Di Giuseppe; Paolo Marinelli; Italo F Angelillo
Journal:  BMC Cancer       Date:  2008-06-11       Impact factor: 4.430

9.  Barriers to colorectal cancer screening in community health centers: a qualitative study.

Authors:  Karen E Lasser; John Z Ayanian; Robert H Fletcher; Mary-Jo DelVecchio Good
Journal:  BMC Fam Pract       Date:  2008-02-27       Impact factor: 2.497

10.  The UK colorectal cancer screening pilot: results of the second round of screening in England.

Authors:  D Weller; D Coleman; R Robertson; P Butler; J Melia; C Campbell; R Parker; J Patnick; S Moss
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

View more
  13 in total

1.  Awareness and attitudes of Greek medical students on colorectal cancer screening.

Authors:  Ioannis S Papanikolaou; Athanasios D Sioulas; Stylianos Kalimeris; Persephone Papatheodosiou; Ioannis Karabinis; Olga Agelopoulou; Iosif Beintaris; Dimitrios Polymeros; George Dimitriadis; Konstantinos Triantafyllou
Journal:  World J Gastrointest Endosc       Date:  2012-11-16

Review 2.  Diagnostic value of interleukin-8 in colorectal cancer: a case-control study and meta-analysis.

Authors:  Wen-Jun Jin; Jin-Ming Xu; Wen-Li Xu; Dong-Hua Gu; Pei-Wei Li
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Assessing awareness of colorectal cancer symptoms and screening in a peripheral colorectal surgical unit: a survey based study.

Authors:  Terri P McVeigh; Aoife J Lowery; Ronan M Waldron; Akhtar Mahmood; Kevin Barry
Journal:  BMC Surg       Date:  2013-06-22       Impact factor: 2.102

4.  Can an alert in primary care electronic medical records increase participation in a population-based screening programme for colorectal cancer? COLO-ALERT, a randomised clinical trial.

Authors:  Carolina Guiriguet-Capdevila; Laura Muñoz-Ortiz; Irene Rivero-Franco; Carme Vela-Vallespín; Mercedes Vilarrubí-Estrella; Miquel Torres-Salinas; Jaume Grau-Cano; Andrea Burón-Pust; Cristina Hernández-Rodríguez; Antonio Fuentes-Peláez; Dolores Reina-Rodríguez; Rosa De León-Gallo; Leonardo Mendez-Boo; Pere Torán-Monserrat
Journal:  BMC Cancer       Date:  2014-03-31       Impact factor: 4.430

5.  Highly sensitive, non-invasive detection of colorectal cancer mutations using single molecule, third generation sequencing.

Authors:  Giancarlo Russo; Andrea Patrignani; Lucy Poveda; Frederic Hoehn; Bettina Scholtka; Ralph Schlapbach; Alex M Garvin
Journal:  Appl Transl Genom       Date:  2015-10-16

Review 6.  Molecular Diagnostic Applications in Colorectal Cancer.

Authors:  Laura Huth; Jörg Jäkel; Edgar Dahl
Journal:  Microarrays (Basel)       Date:  2014-06-26

7.  Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.

Authors:  Ji-Won Huh; Tae-Young Roh
Journal:  BMC Microbiol       Date:  2020-07-13       Impact factor: 3.605

8.  A novel multiplex-protein array for serum diagnostics of colon cancer: a case-control study.

Authors:  Stefanie Bünger; Ulrike Haug; Maria Kelly; Nicole Posorski; Katja Klempt-Giessing; Andrew Cartwright; Stephen P Fitzgerald; Vicki Toner; Damien McAleer; Timo Gemoll; Tilman Laubert; Jürgen Büning; Klaus Fellermann; Hans-Peter Bruch; Uwe J Roblick; Hermann Brenner; Ferdinand von Eggeling; Jens K Habermann
Journal:  BMC Cancer       Date:  2012-09-07       Impact factor: 4.430

9.  A Multilevel Approach to Understand the Context and Potential Solutions for Low Colorectal Cancer (CRC) Screening Rates in Rural Appalachia Clinics.

Authors:  Jamie Zoellner; Kathleen Porter; Esther Thatcher; Erin Kennedy; James L Werth; Betsy Grossman; Tomas Roatsey; Heather Hamilton; Roger Anderson; Wendy Cohn
Journal:  J Rural Health       Date:  2020-10-07       Impact factor: 5.667

10.  Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis.

Authors:  Shirong Yan; Zijing Liu; Shuang Yu; Yixi Bao
Journal:  Med Sci Monit       Date:  2016-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.